Catalyst Pharmaceuticals Inc

NASDAQ:CPRX   3:59:51 PM EDT
3.19
+0.09 (+2.90%)
Products, Litigation

Catalyst Pharmaceuticals Announces Ruling On Lawsuit Against FDA & Intent To Appeal

Published: 09/29/2020 21:01 GMT
Catalyst Pharmaceuticals Inc (CPRX) - Catalyst Pharmaceuticals Announces Ruling on Lawsuit Against the FDA and Intent to Appeal.
Catalyst Pharmaceuticals- Federal Judge Handling Co's Case Against FDA Has Adopted Previously Reported Report, Recommendation of Magistrate Judge.
Catalyst Pharmaceuticals Inc - Intends to Appeal Result to Eleventh Circuit Court of Appeals.
Catalyst Pharmaceuticals - As a Result of District Judge's Decision, Ruzurgi Remains Approved for Treatment of Pediatric Lems Patients in U.S.